Market Insights Health Medical Technology Medical Devices

Diagnostic Imaging Devices - Mexico

Mexico

The projected revenue in the Diagnostic Imaging Devices market market in Mexico is expected to reach €0.82bn by 2024.
This market is anticipated to show an annual growth rate (CAGR 2024-2029) of 4.26%, leading to a market volume of €1.01bn by 2029.
When compared globally, the United States is expected to generate the highest revenue in this market, with €11,060.00m in 2024.
The demand for diagnostic imaging devices in Mexico is driven by the increasing focus on improving healthcare infrastructure and access to quality medical services.

Key regions: Germany, Japan, Netherlands, Spain, United States

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Diagnostic Imaging Devices market in Mexico is experiencing steady growth due to increasing customer preferences for advanced medical technology and a growing healthcare sector.

Customer preferences: Customers in Mexico are increasingly seeking diagnostic imaging devices that offer high-quality imaging capabilities, improved accuracy, and faster results. They prefer devices that are user-friendly, compact, and portable, allowing for greater convenience and flexibility in medical settings. Additionally, there is a growing demand for devices that offer a wide range of imaging modalities, such as X-ray, ultrasound, CT scans, and MRI, to cater to diverse medical needs.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in Mexico is the adoption of digital imaging technology. Digital imaging allows for more efficient and accurate diagnosis, as well as easier storage and sharing of medical images. This trend is driven by advancements in imaging software and hardware, which have made digital imaging more accessible and affordable for healthcare providers in Mexico. Another trend in the market is the increasing use of artificial intelligence (AI) in diagnostic imaging devices. AI algorithms can analyze medical images and assist healthcare professionals in making accurate diagnoses, leading to improved patient outcomes. This trend is expected to continue as AI technology advances and becomes more integrated into diagnostic imaging devices.

Local special circumstances: Mexico has a rapidly growing healthcare sector, with increasing government investments in healthcare infrastructure and services. This has led to a greater demand for diagnostic imaging devices to support the diagnosis and treatment of various medical conditions. Additionally, Mexico has a large population, which further drives the demand for diagnostic imaging devices. The country also has a high prevalence of chronic diseases, such as cardiovascular diseases and cancer, which require regular monitoring and diagnosis using imaging devices. These factors contribute to the growth of the Diagnostic Imaging Devices market in Mexico.

Underlying macroeconomic factors: The growth of the Diagnostic Imaging Devices market in Mexico is also influenced by underlying macroeconomic factors. Mexico has a stable economy and a growing middle class, which has led to increased healthcare spending and improved access to healthcare services. The government has implemented healthcare reforms to expand coverage and improve healthcare quality, which has further boosted the demand for diagnostic imaging devices. Additionally, Mexico is a popular destination for medical tourism, with many international patients seeking advanced medical treatments, including diagnostic imaging services. This has created a favorable market environment for diagnostic imaging device manufacturers and suppliers in Mexico. In conclusion, the Diagnostic Imaging Devices market in Mexico is experiencing steady growth due to increasing customer preferences for advanced medical technology, the adoption of digital imaging and AI technology, a growing healthcare sector, and underlying macroeconomic factors. These factors are driving the demand for diagnostic imaging devices and creating opportunities for market players in Mexico.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.